Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-12

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for methylphenidate hydrochloride, resulting in an approved modification to the product's status. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)